PWMAG
REGN icon

Pinnacle Wealth Management Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.87M Buy
2,415
+178
+8% +$136K 0.13% 123
2025
Q4 		$1.73M Buy
2,237
+710
+46% +$482K 0.12% 119
2025
Q3 		$859K Buy
1,527
+233
+18% +$132K 0.06% 167
2025
Q2 		$679K Sell
1,294
-234
-15% -$131K 0.06% 183
2025
Q1 		$969K Buy
1,528
+487
+47% +$335K 0.09% 140
2024
Q4 		$742K Sell
1,041
-221
-18% -$185K 0.07% 160
2024
Q3 		$1.33M Buy
1,262
+123
+11% +$137K 0.13% 113
2024
Q2 		$1.2M Buy
1,139
+376
+49% +$364K 0.12% 120
2024
Q1 		$734K Buy
763
+63
+9% +$59.9K 0.08% 152
2023
Q4 		$615K Hold
700
– – 0.07% 158
2023
Q3 		$576K Buy
700
+4
+0.6% +$3.14K 0.07% 162
2023
Q2 		$500K Sell
696
-50
-7% -$38.5K 0.06% 182
2023
Q1 		$613K Buy
746
+88
+13% +$66.4K 0.08% 159
2022
Q4 		$475K Buy
658
+77
+13% +$56.8K 0.07% 175
2022
Q3 		$400K Buy
581
+152
+35% +$95.7K 0.07% 180
2022
Q2 		$254K Buy
+429
New +$279K 0.04% 248

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's REGN Position: Q1 2026 in Review

Pinnacle Wealth Management Advisory Group increased its Regeneron Pharmaceuticals (REGN) stake by 8% in Q1 2026, buying an estimated $136K and bringing the position to 2,415 shares worth $1.87M. The position accounts for 0.13% of the portfolio, ranked #123.

Pinnacle Wealth Management Advisory Group first reported a position in REGN in Q2 2022 and has held it in 16 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Pinnacle Wealth Management Advisory Group held 2,415 shares of Regeneron Pharmaceuticals worth $1.87M as of Q1 2026.
  • Pinnacle Wealth Management Advisory Group bought 178 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $136K.
  • Regeneron Pharmaceuticals made up 0.13% of Pinnacle Wealth Management Advisory Group's portfolio in Q1 2026, its #123 holding.
  • Pinnacle Wealth Management Advisory Group first reported a position in Regeneron Pharmaceuticals in Q2 2022 and has held it in 16 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.